Cargando…

ODP164 Asynchronous Diabetes Virtual Interventions, Support, & Empowerment (ADVISE) Program to Improve Glycemic Control in High-Risk Youth and Adults with Type 1 Diabetes

BACKGROUND: The use of personalized text messages to support and empower people with type 1 diabetes(T1D) has the potential to improve glycemic control, particularly in the parts of the world where access to high-quality diabetes care remains limited. Here, we examine the impact of the "Asynchr...

Descripción completa

Detalles Bibliográficos
Autores principales: Alharthi, Sahar, AlShirah, Bashayer, BinMuneif, Yasser, Ibrahim, Eman, Education, Health, Al-Sofiani, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624748/
http://dx.doi.org/10.1210/jendso/bvac150.619
_version_ 1784822310686949376
author Alharthi, Sahar
AlShirah, Bashayer
BinMuneif, Yasser
Ibrahim, Eman
Education, Health
Al-Sofiani, Mohammed
author_facet Alharthi, Sahar
AlShirah, Bashayer
BinMuneif, Yasser
Ibrahim, Eman
Education, Health
Al-Sofiani, Mohammed
author_sort Alharthi, Sahar
collection PubMed
description BACKGROUND: The use of personalized text messages to support and empower people with type 1 diabetes(T1D) has the potential to improve glycemic control, particularly in the parts of the world where access to high-quality diabetes care remains limited. Here, we examine the impact of the "Asynchronous Diabetes Virtual Interventions, Support, & Empowerment" (ADVISE) program on glycemic control in high-risk youth and young adults with T1D in Saudi Arabia. METHODS: We retrospectively coded all text messages, exchanged between healthcare professionals(HCPs) and patients with T1D enrolled in the ADVISE program between January and October 2020. Messages were categorized according to their direction ("outgoing" from HCPs to patients versus "incoming" from patients to HCPs) and type (problem-solving, coaching, encouraging, rapport building, strategic questioning, or appointment scheduling-related texts). Then, we examined: a) the change in patients’ A1C and CGM metrics from pre- to post-enrollment in the ADVISE program and b) the association between the type, direction, and frequency of the texts and change in glycemic control. RESULTS: The ADVISE program enrolled 74 high-risk youth and young adults with T1D [58% women, with a median(IQR) age of 20(16,27) years old and duration of diabetes of 8(4,14) years and an average pre-enrollment A1C of 10.1%]. Out of the 3,457 texts, exchanged between HCPs and patients with T1D, 2642 (76%) were outgoing from HCPs to patients, 815(24%) were incoming from patients to HCPs, and 2,203(83% of the outgoing texts) were coaching-related. Overall, A1C, TIR, and TAR have significantly improved throughout the study period. Patients who received virtual adjustments of insulin doses as part of the ADVISE program had significant improvements in TIR (from baseline: 41% to Month-3: 53% to Month-6: 55%) and TAR (Baseline: 52% to Month-3: 39% to Month-6: 37%). Whereas patients who received no virtual adjustments of insulin dose had no significant changes in any of the glycemic metrics. When examined by frequency of incoming texts, patients who sent ≥1 text/month to their HCPs noted significant improvements in TIR, TAR, and A1C, whereas those who sent <1 text/month noted no significant changes in any of the glycemic metrics. Similarly, A1C has significantly improved (from 9.6% to 8.6%, p<0. 01) in patients who received ≥8 texts/month from their HCPs, whereas those who received <8 texts/month had no significant change in A1C (9. 05% to 9%, p=0.24). CONCLUSION: Our ADVISE program applies the four principles "Ps" of precision medicine to diabetes care (Predictive, Preventive, Personalized, and Participative) and is associated with significant improvements in various glycemic metrics in high-risk youth and young adults with T1D. Our findings have implications to mitigate the health- and economic- burden of diabetes, particularly in parts of the world where diabetes is highly prevalent and access to high-quality care is limited. Presentation: No date and time listed
format Online
Article
Text
id pubmed-9624748
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96247482022-11-14 ODP164 Asynchronous Diabetes Virtual Interventions, Support, & Empowerment (ADVISE) Program to Improve Glycemic Control in High-Risk Youth and Adults with Type 1 Diabetes Alharthi, Sahar AlShirah, Bashayer BinMuneif, Yasser Ibrahim, Eman Education, Health Al-Sofiani, Mohammed J Endocr Soc Diabetes & Glucose Metabolism BACKGROUND: The use of personalized text messages to support and empower people with type 1 diabetes(T1D) has the potential to improve glycemic control, particularly in the parts of the world where access to high-quality diabetes care remains limited. Here, we examine the impact of the "Asynchronous Diabetes Virtual Interventions, Support, & Empowerment" (ADVISE) program on glycemic control in high-risk youth and young adults with T1D in Saudi Arabia. METHODS: We retrospectively coded all text messages, exchanged between healthcare professionals(HCPs) and patients with T1D enrolled in the ADVISE program between January and October 2020. Messages were categorized according to their direction ("outgoing" from HCPs to patients versus "incoming" from patients to HCPs) and type (problem-solving, coaching, encouraging, rapport building, strategic questioning, or appointment scheduling-related texts). Then, we examined: a) the change in patients’ A1C and CGM metrics from pre- to post-enrollment in the ADVISE program and b) the association between the type, direction, and frequency of the texts and change in glycemic control. RESULTS: The ADVISE program enrolled 74 high-risk youth and young adults with T1D [58% women, with a median(IQR) age of 20(16,27) years old and duration of diabetes of 8(4,14) years and an average pre-enrollment A1C of 10.1%]. Out of the 3,457 texts, exchanged between HCPs and patients with T1D, 2642 (76%) were outgoing from HCPs to patients, 815(24%) were incoming from patients to HCPs, and 2,203(83% of the outgoing texts) were coaching-related. Overall, A1C, TIR, and TAR have significantly improved throughout the study period. Patients who received virtual adjustments of insulin doses as part of the ADVISE program had significant improvements in TIR (from baseline: 41% to Month-3: 53% to Month-6: 55%) and TAR (Baseline: 52% to Month-3: 39% to Month-6: 37%). Whereas patients who received no virtual adjustments of insulin dose had no significant changes in any of the glycemic metrics. When examined by frequency of incoming texts, patients who sent ≥1 text/month to their HCPs noted significant improvements in TIR, TAR, and A1C, whereas those who sent <1 text/month noted no significant changes in any of the glycemic metrics. Similarly, A1C has significantly improved (from 9.6% to 8.6%, p<0. 01) in patients who received ≥8 texts/month from their HCPs, whereas those who received <8 texts/month had no significant change in A1C (9. 05% to 9%, p=0.24). CONCLUSION: Our ADVISE program applies the four principles "Ps" of precision medicine to diabetes care (Predictive, Preventive, Personalized, and Participative) and is associated with significant improvements in various glycemic metrics in high-risk youth and young adults with T1D. Our findings have implications to mitigate the health- and economic- burden of diabetes, particularly in parts of the world where diabetes is highly prevalent and access to high-quality care is limited. Presentation: No date and time listed Oxford University Press 2022-11-01 /pmc/articles/PMC9624748/ http://dx.doi.org/10.1210/jendso/bvac150.619 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Diabetes & Glucose Metabolism
Alharthi, Sahar
AlShirah, Bashayer
BinMuneif, Yasser
Ibrahim, Eman
Education, Health
Al-Sofiani, Mohammed
ODP164 Asynchronous Diabetes Virtual Interventions, Support, & Empowerment (ADVISE) Program to Improve Glycemic Control in High-Risk Youth and Adults with Type 1 Diabetes
title ODP164 Asynchronous Diabetes Virtual Interventions, Support, & Empowerment (ADVISE) Program to Improve Glycemic Control in High-Risk Youth and Adults with Type 1 Diabetes
title_full ODP164 Asynchronous Diabetes Virtual Interventions, Support, & Empowerment (ADVISE) Program to Improve Glycemic Control in High-Risk Youth and Adults with Type 1 Diabetes
title_fullStr ODP164 Asynchronous Diabetes Virtual Interventions, Support, & Empowerment (ADVISE) Program to Improve Glycemic Control in High-Risk Youth and Adults with Type 1 Diabetes
title_full_unstemmed ODP164 Asynchronous Diabetes Virtual Interventions, Support, & Empowerment (ADVISE) Program to Improve Glycemic Control in High-Risk Youth and Adults with Type 1 Diabetes
title_short ODP164 Asynchronous Diabetes Virtual Interventions, Support, & Empowerment (ADVISE) Program to Improve Glycemic Control in High-Risk Youth and Adults with Type 1 Diabetes
title_sort odp164 asynchronous diabetes virtual interventions, support, & empowerment (advise) program to improve glycemic control in high-risk youth and adults with type 1 diabetes
topic Diabetes & Glucose Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624748/
http://dx.doi.org/10.1210/jendso/bvac150.619
work_keys_str_mv AT alharthisahar odp164asynchronousdiabetesvirtualinterventionssupportempowermentadviseprogramtoimproveglycemiccontrolinhighriskyouthandadultswithtype1diabetes
AT alshirahbashayer odp164asynchronousdiabetesvirtualinterventionssupportempowermentadviseprogramtoimproveglycemiccontrolinhighriskyouthandadultswithtype1diabetes
AT binmuneifyasser odp164asynchronousdiabetesvirtualinterventionssupportempowermentadviseprogramtoimproveglycemiccontrolinhighriskyouthandadultswithtype1diabetes
AT ibrahimeman odp164asynchronousdiabetesvirtualinterventionssupportempowermentadviseprogramtoimproveglycemiccontrolinhighriskyouthandadultswithtype1diabetes
AT educationhealth odp164asynchronousdiabetesvirtualinterventionssupportempowermentadviseprogramtoimproveglycemiccontrolinhighriskyouthandadultswithtype1diabetes
AT alsofianimohammed odp164asynchronousdiabetesvirtualinterventionssupportempowermentadviseprogramtoimproveglycemiccontrolinhighriskyouthandadultswithtype1diabetes